AR and breast cancer: To verify the high frequency of PIK3CA mutations in TNBC tumors with elevated levels of AR protein, we analyzed the RNA-seq, DNA-seq and reverse-phase protein array (RPPA) data in TCGA breast cancer cohort [6].